Blue Distinction by Blue Cross

Blue Distinction

Fox Chase Cancer Center has been designated as one of the Blue Distinction CentersSM for Complex and Rare Cancers by Blue Cross Blue Shield Association and Independence Blue Cross. 

With complex and rare cancers comprising approximately 15 percent of new cancer cases each year, it is difficult for patients to locate and/or research facilities that specialize in this area — the Blue Distinction designation helps patients identify institutions with expertise in this specialty. 

Blue Distinction is a nationwide program created by Blue Cross Blue Shield Association to give consumers the information they need to make smart health care decisions and to work with their health care providers on improving the quality and affordability of their medical care. Blue Distinction identifies specialty centers that offer the best practices and highest standards in cardiac care, bariatric surgery, transplants and now complex and rare cancers.

The complex and rare cancers designation is awarded to institutions that offer multidisciplinary treatment planning and complex, major surgical treatments with subspecialty training and distinguished clinical expertise in complex and rare cancer such as esophageal cancer, bladder cancer, liver cancer, thyroid cancer, and 10 other complex and rare subtypes of cancer.

Fox Chase has earned the Blue Distinctions Center for Complex and Rare Cancers designation for esophageal cancer, pancreatic cancer, gastric cancer, rectal cancer, bladder cancer, head and neck cancer, thyroid cancer and soft tissue sarcoma. 

Fox Chase has earned
Blue Distinction CenterSM for Complex and Rare Cancers designation
for treatment of
esophageal cancer,
pancreatic cancer,
gastric cancer,
rectal cancer,
bladder cancer,
head and neck cancer,
thyroid cancer,
and 
soft tissue sarcoma.

Selection criteria for this designation are based on objective, evidence-based measurements for clinical care.

All Blue Distinction Centers for Complex and Rare Cancers provide:

  • multidisciplinary team input, including sub-specialty trained teams for complex and rare cancers and demonstrated depth of expertise across cancer disciplines in medicine, surgery, radiation oncology, pathology, and radiology;
  • ongoing quality management and improvement programs for cancer care;
  • ongoing commitment to using clinical data registries and providing access to appropriate clinical research for complex and rare cancers;
  • sufficient volume of experience in treating rare and complex cancers.

Blue Distinction Centers for Complex and Rare Cancers were developed in strategic collaboration with the National Comprehensive Cancer Network and input from leading clinicians and professional organizations.